ASC leaders anticipate a continuing uptick in private equity deals and consolidation and the average value of transactions have generally increased year over year over the last decade, according to a report by data company PitchBook.
Here is the total value of the private equity deals that took place in the U.S. healthcare market from Jan. 1, 2012, to Oct. 19, 2022.
Note: 2022 data does not reflect the entire year and is an estimate based on the year’s private equity activity at the time of the report.
|
Year |
No. of deals |
Total value of deals |
|
2012 |
443 |
$45.3 billion |
|
2013 |
413 |
$31.3 billion |
|
2014 |
542 |
$50.1 billion |
|
2015 |
594 |
$66.6 billion |
|
2016 |
676 |
$59.2 billion |
|
2017 |
811 |
$102.1 billion |
|
2018 |
983 |
$97.9 billion |
|
2019 |
951 |
$119.4 billion |
|
2020 |
1,065 |
$103.7 billion |
|
2021 |
1,454 |
$216.7 billion |
|
2022 |
1,318* |
$111.7 billion* |
*Estimated number of deals and total value by Dec. 31, 2022.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.